Anthelos Ltd. has developed, with EU support, a new immunochemical technology, which helps to detect cancer and autoimmune diseases more precisely than before, in the framework of a project costing almost HUF 160 million. The company received a conditional non-reimbursable EU grant of HUF 111.46 million for the development. László Puskás, the head of the […]